[{"from": "human", "value": "Please give me some details about this molecule. [C][C][=C][C][=Branch1][=Branch2][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][O][C][C][C][C][Branch1][C][C][Branch1][C][C][C][=Branch1][C][=O][O]"}, {"from": "gpt", "value": "The molecule is a fibric acid agent, similar to [clofibrate], used to treat Type IIb, IV, and V hyperlipidemias. Gemfibrozil is not a first line treatment and is prescribed to patients who have not responded adequately to weight loss, diet, exercise, and other medications.  Gemfibrozil was granted FDA approval on 21 December 1981."}]